Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2025-2031

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2025-2031

The global Anti-inflammatory Therapeutics market size is predicted to grow from US$ 121620 million in 2025 to US$ 175750 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

LPI (LP Information)' newest research report, the “Anti-inflammatory Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Therapeutics sales for 2025 through 2031. With Anti-inflammatory Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-inflammatory Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Segmentation by Application:
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA